FSA publishes list of permitted CBD products
The UK has become the first country in the world to regulate the market for safe, oral cannabidiol (CBD) products with the release on 31st March of the […]
The UK has become the first country in the world to regulate the market for safe, oral cannabidiol (CBD) products with the release on 31st March of the […]
The coronavirus pandemic has had a huge impact on mental health in general but especially on health care workers and on children, according to Professor Lynn Crismon. Commenting […]
While potentially crucial to preventing the spread of COVID-19, lockdowns are associated with increased rates of depression and anxiety as well as food insecurity among women in India […]
A request from the medical director to review the prescribing of psychotropic drugs in a small hospital serving the Navajo population stimulated a career interest in psychiatric disease […]
Obese mice that were fed a high-fat diet and that received prednisone one time per week had improved exercise endurance, got stronger, increased their lean body mass and […]
Early in his career Professor Lynn Crismon worked in the US Public Health Service on the Navajo reservation where he learned much about communicable diseases, including bubonic plague. […]
Many brain diseases and disorders lead to neuroinflammation, a swelling of brain tissue that is increasingly recognized as one of the telltale signs and disease progression factors of […]
Professor M Lynn Crismon received the 2021 American Society of Health System Pharmacists award for excellence in pharmacy practice leadership. IMI spoke to him to find out more […]
Exercising for half an hour may reduce symptoms of depression for at least 75 minutes post-workout and amplify the benefits of therapy, according to two new studies led […]
Covid-19 patients are at increased risk of developing type 2 diabetes, researchers reported on March 21, 2022 in Diabetologia. “Put simply, this means that the relative risk of developing […]
Early aspirin therapy appears to reduce mortality among patients with moderate COVID-19, researchers reported on March 24, 2022 in JAMA Network Open. “This is our third study and […]
Pharmacogenomic testing for safety and efficacy of common medicines should be offered via the NHS, according to a report from the Royal College of Physicians and the British […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.